domingo, 21 de diciembre de 2025

FDA approves amivantamab and hyaluronidase-lpuj for subcutaneous injection

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-amivantamab-and-hyaluronidase-lpuj-subcutaneous-injection?utm_medium=email&utm_source=govdelivery

No hay comentarios:

Publicar un comentario